INJ Price Holds $12.98 Despite Exchange Delistings and Regulatory Headwinds
The post INJ Price Holds $12.98 Despite Exchange Delistings and Regulatory Headwinds appeared on BitcoinEthereumNews.com.
Joerg Hiller Sep 01, 2025 08:22 Injective (INJ) trades at $12.98 with neutral RSI at 45.79 as regulatory pressures trigger exchange delistings, creating mixed technical signals for traders. Quick Take • INJ currently trading at $12.98 (+0.08% in 24h) • Injective’s RSI at 45.79 indicates neutral momentum amid regulatory uncertainty • Exchange delistings drive 22.22% weekly decline as compliance issues mount What’s Driving Injective Price Today? The INJ price has stabilized around $12.97-$12.98 following a turbulent week marked by significant regulatory challenges. The most impactful development occurred on August 27, when Injective experienced a sharp 22.22% decline in a single day due to mounting regulatory scrutiny and compliance concerns. Major cryptocurrency exchanges have begun delisting INJ tokens over regulatory compliance issues, creating immediate selling pressure and raising questions about the protocol’s operational stability. The delistings were accompanied by reports of staff layoffs and paused product development, signaling deeper organizational challenges beyond just regulatory pressure. Most recently, on August 31, the INJ price dropped to $12.97 as these regulatory pressures continued to weigh on investor sentiment. The regulatory uncertainty has created a cautious market environment where traders are closely monitoring for any updates on compliance resolutions or further exchange actions. Despite these challenges, the current INJ price action shows some stabilization, with today’s modest 0.08% gain suggesting that the immediate panic selling may have subsided. However, the 24-hour trading volume of $10.1 million on Binance spot market indicates relatively muted interest compared to previous weeks. INJ Technical Analysis: Neutral Signals Emerge Amid Bearish Backdrop The current Injective technical analysis reveals a complex picture with mixed signals across different timeframes. Injective’s RSI sits at 45.79, placing it firmly in neutral territory and suggesting that neither bulls nor bears have decisive control at current levels.…
